Harvard Bioscience, Inc. (HBIO) Reports Q2 Earnings of $0.08
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.35 +0.36%
Revenue Growth %: +6.1%
Financial Fact:
Revenues: 25.01M
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: +6.1%
Financial Fact:
Revenues: 25.01M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q2 EPS of $0.08, versus $0.08 reported last year. Revenue for the quarter came in at $27.1 million, versus $25.9 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood shares fall on Q3 revenue miss even as EPS beats
- Artisan Partners Asset Management (APAM) Tops Q3 EPS by 7c
- NBT Bancorp (NBTB) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
